With 8.98 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.86 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.18 whereas the lowest price it dropped to was $0.855. The 52-week range on TRIB shows that it touched its highest point at $3.39 and its lowest point at $0.48 during that stretch. It currently has a 1-year price target of $15.00. TRIB paid its most recent dividend on 1433462400, while the ex-dividend date for that was 1433462400. Beta for the stock currently stands at 0.88.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TRIB was up-trending over the past week, with a rise of 25.56%, but this was up by 52.43% over a month. Three-month performance surged to 54.77% while six-month performance rose 46.43%. The stock gained 28.38% in the past year, while it has lost -56.03% so far this year.
Float and Shares Shorts:
At present, 18.05 million TRIB shares are outstanding with a float of 17.41 million shares on hand for trading. On 2025-07-31, short shares totaled 0.37 million, which was 198.00000000000003 higher than short shares on 1751241600. In addition to Mr. John Gillard as the firm’s President, CEO, Company Secretary & Director, Mr. Ronan O’Caoimh A.C.A. serves as its Founder, Director & Executive Advisor.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-12-31, TRIB reported revenue of $15857000.0 and operating income of -$8564000.0. The EBITDA in the recently reported quarter was -$8428000.0 and diluted EPS was $nan.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.74 being high and -$1.74 being low. For TRIB, this leads to a yearly average estimate of -$1.74. The surprise factor in the prior quarter was -$0.3. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
